XML 55 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment Information (Tables)
 12 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Segment net revenues by major payer source
Segment net revenues by major payer source were as follows (in millions): 
 
For Year
 
2012
 
2011
 
2010
 
Home
Health
 
Hospice
 
Total
 
Home
Health
 
Hospice
 
Total
 
Home
Health
 
Hospice
 
Total
Medicare
$
749.0

 
$
715.5

 
$
1,464.6

 
$
799.2

 
$
729.1

 
$
1,528.3

 
$
822.7

 
$
326.2

 
$
1,148.9

Medicaid and Local Government
46.8

 
27.7

 
74.4

 
52.3

 
30.8

 
83.1

 
59.8

 
14.2

 
74.0

Commercial Insurance and Other:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Paid at episodic rates
85.2

 
—

 
85.2

 
77.7

 
—

 
77.7

 
86.4

 
—

 
86.4

Other
67.0

 
21.6

 
88.6

 
83.4

 
26.3

 
109.7

 
94.1

 
11.1

 
105.2

Total net revenues
$
948.0

 
$
764.8

 
$
1,712.8

 
$
1,012.6

 
$
786.2

 
$
1,798.8

 
$
1,063.0

 
$
351.5

 
$
1,414.5
Segment information about the Company's operations
Segment information about the Company's operations is as follows (in thousands):
 
Home Health
 
 
 
Hospice
 
 
Total
 
 
For the for the year ended December 31, 2012
 
 
 
 
 
 
 
 
 
 
Net revenue
$
948,019

 
  
 
$
764,785

  
 
$
1,712,804

 
  
Operating contribution
$
125,445

 
(1
)
 
$
133,133

(1
)
 
$
258,578

 
  
Corporate expenses
 
 
 
 
 
 
 
(83,700
)
 
(1
)
Goodwill, intangibles and other long-lived asset impairment
 
 
 
 
 
 
 
(19,132
)
 
(3
)
Depreciation and amortization
 
 
 
 
 
 
 
(26,581
)
 
 
Gain on sale of businesses
 
 
 
 
 
 
 
8,014

 
  
Interest expense and other, net
 
 
 
 
 
 
 
(89,947
)
 
(2
)
Income from continuing operations before income taxes and equity in loss of affiliate
 
 
 
 
 
 
 
$
47,232

 
  
Segment assets
$
242,603

 
(3
)
 
$
858,502

(3
)
 
$
1,101,105

 
  
Corporate assets
 
 
 
 
 
 
 
409,829

 
  
Total assets
 
 
 
 
 
 
 
$
1,510,934

 
  
For the for the year ended December 31, 2011
 
 
 
 
 
 
 
 
 
 
Net revenue
$
1,012,566

 
  
 
$
786,212

  
 
$
1,798,778

 
  
Operating contribution
$
126,194

 
(1
)
 
$
139,723

(1
)
 
$
265,917

 
  
Corporate expenses
 
 
 
 
 
 
 
(115,861
)
 
(1
)
Goodwill, intangibles and other long-lived asset impairment
 
 
 
 
 
 
 
(643,305
)
 
(3
)
Dividend income
 
 
 
 
 
 
 
8,590

 
(4
)
Depreciation and amortization
 
 
 
 
 
 
 
(30,140
)
 
 
Gain on sale of assets and businesses, net
 
 
 
 
 
 
 
1,061

 
 
Interest expense and other, net
 
 
 
 
 
 
 
(88,610
)
 
(2
)
Loss from continuing operations before income taxes and equity in earnings of affiliate
 
 
 
 
 
 
 
$
(602,348
)
 
  
Segment assets
$
239,751

 
(3
)
 
$
905,284

(3
)
 
$
1,145,035

 
  
Corporate assets
 
 
 
 
 
 
 
385,293

 
  
Total assets
 
 
 
 
 
 
 
$
1,530,328

 
  
For the for the year ended December 31, 2010
 
 
 
 
 
 
 
 
 
 
Net revenue
$
1,062,944

 
  
 
$
351,515

 
 
$
1,414,459

 
  
Operating contribution
$
205,469

 
(1
)
 
$
72,276

(1
)
 
$
277,745

 
  
Corporate expenses
 
 
 
 
 
 
 
(127,745
)
 
(1
)
Depreciation and amortization
 
 
 
 
 
 
 
(22,479
)
 
 
Gain on sale of assets and businesses, net
 
 
 
 
 
 
 
103

 

Interest expense and other, net
 
 
 
 
 
 
 
(39,030
)
 


Loss from continuing operations before income taxes and equity in earnings of affiliate
 
 
 
 
 
 
 
$
88,594

 
  
Segment assets
$
656,540

 


 
$
1,054,006



 
$
1,710,546

 
  
Corporate assets
 
 
 
 
 
 
 
409,582

 
(3
)
Total assets
 
 
 
 
 
 
 
$
2,120,128

 
  
(1)
For the years ended December 31, 2012, 2011 and 2010, the Company recorded charges relating to cost savings initiatives and other restructuring costs, acquisition and integration costs and legal settlements of $5.7 million, $49.1 million and $46.0 million, respectively. See Note 10 for additional information.
Charges reflecting for segment reporting purposes The charges were reflected as follows for segment reporting purposes (in millions): 2012 2011 2010Home Health$5.6 $7.7 $11.8Hospice0.4 3.7 0.3Corporate expenses(0.3) 37.7 33.9Total$5.7 $49.1 $46.0(2)For the year ended December 31, 2012, interest expense and other, net included charges of $0.5 million relating to the write-off of deferred debt issuance costs associated with the revolving credit facility. In addition, interest expense and other, net for the year ended December 31, 2011 included charges of $3.8 million associated with terminating the Company’s interest rate swaps in connection with the refinancing of the Company’s Term Loan A and Term Loan B under the Company’s credit agreement. See Note 10 for additional information.(3)For the year ended December 31, 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name. Home Health and Hospice assets were reduced by $6.0 million and $13.1 million, respectively, as of December 31, 2012 as a result of the impairment.For the year ended December 31, 2011, the Company recorded non-cash impairment charges associated with goodwill, intangibles and other long-lived assets of $643.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a significant decline in the price of the Company's common stock during the fiscal year, (iv) a write-down of software and (v) a change in the estimated fair value of real estate. Home Health, Hospice and corporate assets were reduced by $408.4 million, $193.7 million and $41.2 million, respectively, as of December 31, 2011, as a result of the impairment.(4)For the year ended December 31, 2011, the Company recognized dividend income of $8.6 million as a result of the sale of a portion of the Company’s combined common and preferred ownership of CareCentrix.